Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $630.3000 (1.13%) ($630.3000 - $632.7200) on Thu. Mar. 10, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.56% (three month average) | RSI | 50 | Latest Price | $630.3000(1.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.6% a day on average for past five trading days. | Weekly Trend | REGN advances 0.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(57%) DIA(41%) IWD(40%) XLV(40%) SPY(38%) | Factors Impacting REGN price | REGN will decline at least -0.78% in a week (0% probabilities). VIXM(-20%) TBT(-10%) UUP(-8%) VXX(-3%) USO(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.78% (StdDev 1.56%) | Hourly BBV | 2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $621.07(1.49%) | 10 Day Moving Average | $618.03(1.99%) | 20 Day Moving Average | $618.96(1.83%) | To recent high | -6% | To recent low | 5.9% | Market Cap | $66.83b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |